Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Farrelly

Showing results (651-660 of 747) with videos related to

Pageof 75
Sort By:
JAMA Oncology|February 6, 2025
Pembrolizumab in Patients With Advanced Clear Cell Gynecological Cancer: A Phase 2 Nonrandomized Clinical TrialRebecca Kristeleit, Michael-John Devlin, Andrew Clamp, et al.
Bioorganic & Medicinal Chemistry Letters|November 11, 2008
Identification and optimization of N3,N6-diaryl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamines as a novel class of ACK1 inhibitorsDavid J Kopecky, Xiaolin Hao, Yi Chen, et al.
Oncotarget|October 21, 2017
BRAF/MEK inhibitors promote CD47 expression that is reversible by ERK inhibition in melanomaFen Liu, Chen Chen Jiang, Xu Guang Yan, et al.
Cold Spring Harbor Molecular Case Studies|January 5, 2017
Exome sequencing identifies de novo pathogenic variants in <i>FBN1</i> and <i>TRPS1</i> in a patient with a complex connective tissue phenotypeDiane B Zastrow, Patricia A Zornio, Annika Dries, et al.
Obstetrics & Gynecology Science|September 3, 2020
Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancerRoshni D Kalachand, Ciaran O'Riain, Sinead Toomey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2003
Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trialPhilip J Bergman, Joanne McKnight, Andrew Novosad, et al.
Cancer Treatment and Research Communications|April 17, 2025
Targeting the phosphatidylinositol-3-kinase (PI3K) and mitogen activated protein kinase (MAPK) signalling pathways to enhance chemoradiotherapy in locally advanced rectal cancerAoife Carr, Jonathan A Coulter, Julie Workman, et al.
Diabetes|August 5, 2010
INS-1 cells undergoing caspase-dependent apoptosis enhance the regenerative capacity of neighboring cellsCaroline Bonner, Siobhán Bacon, Caoimhín G Concannon, et al.
British Journal of Cancer|May 2, 2022
BRCA mutations lead to XIAP overexpression and sensitise ovarian cancer to inhibitor of apoptosis (IAP) family inhibitorsMattia Cremona, Cassandra J Vandenberg, Angela M Farrelly, et al.
Cancer Research|October 11, 2018
A p53-Responsive miRNA Network Promotes Cancer Cell QuiescenceTing La, Guang Zhi Liu, Margaret Farrelly, et al.
Pageof 75

Showing results (651-660 of 747) with videos related to

Sort By:
Pageof 75
JAMA Oncology|February 6, 2025
Pembrolizumab in Patients With Advanced Clear Cell Gynecological Cancer: A Phase 2 Nonrandomized Clinical TrialRebecca Kristeleit, Michael-John Devlin, Andrew Clamp, et al.
Bioorganic & Medicinal Chemistry Letters|November 11, 2008
Identification and optimization of N3,N6-diaryl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamines as a novel class of ACK1 inhibitorsDavid J Kopecky, Xiaolin Hao, Yi Chen, et al.
Oncotarget|October 21, 2017
BRAF/MEK inhibitors promote CD47 expression that is reversible by ERK inhibition in melanomaFen Liu, Chen Chen Jiang, Xu Guang Yan, et al.
Cold Spring Harbor Molecular Case Studies|January 5, 2017
Exome sequencing identifies de novo pathogenic variants in <i>FBN1</i> and <i>TRPS1</i> in a patient with a complex connective tissue phenotypeDiane B Zastrow, Patricia A Zornio, Annika Dries, et al.
Obstetrics & Gynecology Science|September 3, 2020
Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancerRoshni D Kalachand, Ciaran O'Riain, Sinead Toomey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2003
Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trialPhilip J Bergman, Joanne McKnight, Andrew Novosad, et al.
Cancer Treatment and Research Communications|April 17, 2025
Targeting the phosphatidylinositol-3-kinase (PI3K) and mitogen activated protein kinase (MAPK) signalling pathways to enhance chemoradiotherapy in locally advanced rectal cancerAoife Carr, Jonathan A Coulter, Julie Workman, et al.
Diabetes|August 5, 2010
INS-1 cells undergoing caspase-dependent apoptosis enhance the regenerative capacity of neighboring cellsCaroline Bonner, Siobhán Bacon, Caoimhín G Concannon, et al.
British Journal of Cancer|May 2, 2022
BRCA mutations lead to XIAP overexpression and sensitise ovarian cancer to inhibitor of apoptosis (IAP) family inhibitorsMattia Cremona, Cassandra J Vandenberg, Angela M Farrelly, et al.
Cancer Research|October 11, 2018
A p53-Responsive miRNA Network Promotes Cancer Cell QuiescenceTing La, Guang Zhi Liu, Margaret Farrelly, et al.
Pageof 75